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Genetic causes of autism spectrum disorder
utism spectrum disorders were originally
diagnosed by Kanner and Asperger in the 1930s.1,2
However, the diagnostic criteria were not codified
until the 1994 Diagnostic and Statistical Manual of
Mental Disorders (DSM).3 Astonishingly high heri-
tability of autism spectrum disorders, reaching 90%
concordance for monozygotic twins, as compared with
less than 10% concordance for dizygotic twins and sib-
lings, along with a 4:1 male:female ratio of prevalence,
quickly led to an major international search for genes
causing autism. By assembling large numbers of sim-
plex and familial cases, several research consortia have
discovered single gene mutations, rare and common
polymorphisms, and epigenetic modifications associ-
ated with autism.4,5 Copy number variants, including
duplications of a sequence of genes within defined
chromosomal loci, were reported to be relatively com-
mon in autism.6-9 Clearly, autism is not a single-gene
disorder. 
To parse the role of each of these many genetic abnor-
malities in the etiology and symptomology of autism
spectrum disorders, and in other neurodevelopmental
disorders in which autism is concomitantly diagnosed,
homologous genetic mutations have been generated in
experimental animals. Because the targeted gene
mutation technology was perfected in the mouse, mice
are currently used throughout biomedical research as
the primary model organism for generating transgenic
and knockout mouse models of human genetic disor-
ders. Table I and the descriptions in this review illus-
trate a small portion of the wealth of available mouse
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Autism is a neurodevelopmental disorder whose diagno-
sis is based on three behavioral criteria: unusual recipro-
cal social interactions, deficits in communication, and
stereotyped repetitive behaviors with restricted interests.
A large number of de novo single gene mutations and
chromosomal deletions are associated with autism spec-
trum disorders. Based on the strong genetic evidence,
mice with targeted mutations in homologous genes have
been generated as translational research tools. Mouse
models of autism have revealed behavioral and biological
outcomes of mutations in risk genes. The field is now
poised to employ the most robust phenotypes in the most
replicable mouse models for preclinical screening of novel
therapeutics. 
© 2012, LLS SAS Dialogues Clin Neurosci. 2012;14:293-305.
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models of autism. In addition, recent advances in gen-
erating knockout rats10 are leading to the development
of mutant rat models of neurodevelopmental disor-
ders. 
Because concordance for autism spectrum disorder is
not 100% between identical twins, whose genomes are
presumably identical, environmental and epigenetic
causes of autism spectrum disorders are also under
investigation. Hypotheses about prenatal exposure to
toxicological and immunological insults, and neu-
roanatomical lesions, have been modeled in mice, rats,
and monkeys.11-18 The challenge now is to understand the
consequences of each of these genetic and environmen-
tal perturbations, and their interactions. Animal models
employing behavioral assays relevant to the specific
symptoms offer excellent translational research tools to
identify the biological mechanisms underlying the core
features of autism spectrum disorder.
How do we model the behavioral 
symptoms of autism in mice?
As defined in the DSM-IV,3 the diagnosis of autism
requires the presence of at least six symptoms, includ-
ing a minimum of two measures of qualitative impair-
ment in social interaction, one symptom of qualitative
impairment in communication, and one symptom of
restricted and repetitive behaviour.19,20 The DSM-5 is
expected to redefine Autism Spectrum Disorder into
two symptom domains: (i) Social interaction and social
communication deficits; (ii) Restricted, repetitive pat-
terns of behavior, interests, or activities (http://
www.dsm5.org/ProposedRevisions/Pages/proposed revi-
sion.aspx?rid=94, January 2011). Associated symptoms
that appear in subsets of individuals with autism include
seizures, anxiety, intellectual impairment, hyperactivity,
hyper-responsiveness and hyporesponsiveness to sen-
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Gene Protein Autism-relevant behavioral phenotypes
Integrin 3 Integrin β3 Lack of preference for social novelty 
Increased repetitive self-grooming
Nlgn1 Neuroligin 1 Increased repetitive self-grooming
Nlgn2 Neuroligin 2 Increased anxiety-like behavior
Synaptic Nlgn3 Neuroligin 3 Reduced pup ultrasonic vocalizations
cell-adhesion Sensory abnormalities
proteins Ngln4 Neuroligin 4 Reduced sociability and vocalizations
Neurexin-1 Neurexin-1α Increased repetitive self-grooming
Cntnap2 Contactin-associated protein2 Seizures, reduced social behaviors
Shank3 Shank3 Mild reduction in social interactions and adult vocalizations
En2 Engrailed-2 Reduced social behaviors - Impaired learning and memory
Signaling and Met Tyrosine kinase/ hepatocyte Cognitive deficit
developmental growth factor receptor
proteins Foxp2 Forkhead box protein 2 Reduced pup ultrasonic vocalizations
Pten Phosphatase and tensin homolog Reduced reciprocal social interactions - Reduced sociability
Avrp1 Vasopressin receptor Impaired social recognition - Reduced reciprocal social interaction
Reduced ultrasonic vocalizations
Cadps2 Calcium-dependent secretion Reduced reciprocal social interactions
Neurotransmitters activator 2
and receptors Gabrb3 GABA A receptor beta3 subunit Low sociability - Lack of preference for social novelty
Repetitive stereotyped circling behavior
Oxtr Oxytocin receptor Impaired social recognition - Reduced pup ultrasonic vocalizations
Slc6a4 Solute carrier family 6, member 4 Low sociability
(Serotonin transporter) Lack of preference for social novelty
Table I. Autism-relevant behavioral phenotypes in selected mouse models with targeted mutations in genes associated with autism.155-169
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sory stimuli, sleep disruption, and gastrointestinal dis-
tress.20-26
Given that the defining criteria for autism are behav-
ioral, investigations employing mouse models require
considerable insight into which specific behaviors in the
mouse repertoire are sufficiently relevant to each cate-
gory of the diagnostic symptoms of autism. Inclusion of
behavioral assays relevant to associated symptoms fur-
ther enhance the heuristic value of animal models of
autism spectrum disorders. We and other behavioral
neuroscientists have generated a comprehensive set of
assays for social interaction, social communication, and
repetitive behaviors in mice, to test hypotheses about the
causes of autism.27-45 Social approach, reciprocal social
interactions, olfactory communication, ultrasonic vocal-
izations, motor stereotypies such as circling and vertical
jumping, repetitive behaviors such as self-grooming and
digging, and perserveration in spatial tasks, are now in
routine use for phenotyping mouse and rat models of
autism and other neurodevelopmental disorders.
Procedures for assaying behaviors relevant to associated
symptoms of autism, including neurodevelopmental
milestones, cognitive abilities, anxiety-like tendencies,
seizures, motor dysfunctions, hyperactivity, responsive-
ness to sensory stimuli, and altered sleep patterns in
mice have been adapted from the available behavioral
neuroscience literature.46
In each case, we begin with the human endophenotype.
In what ways are mouse behaviors similar to a defining
feature of autism? Luckily, Mus musculus is a social
species. Laboratory mice display a social repertoire that
includes approach to olfactory pheromones emitted by
other mice, approach to familiar and new conspecifics,
reciprocal social interactions, ultrasonic vocalizations,
communal nesting, sexual and parenting behaviors, ter-
ritorial scent marking, and aggressive behaviors.47-49
Standardized methods for scoring adult social
approaches, reciprocal social interactions, nesting, sex-
ual interactions, parental behaviors, and aggressive
encounters are available in the behavioral neuroscience
literature.28,50-61
First diagnostic category
We employ social assays that have been refined from
standard tests in the behavioral neuroscience litera-
ture.48,49 These choices are designed to maximize rele-
vance to the types of social deficits specific to autism,
including playing alone with inanimate toys rather than
engaging in social interactions, and inappropriate
responses to social cues. To quantify tendencies to
engage in reciprocal social interactions, each subject
mouse is paired with a novel partner mouse, inside a
testing arena that permits free interactions over a test
session of 10 to 30 minutes’ duration. Digital videocam-
eras record the session for later scoring of multiple para-
meters of social interactions. Ratings are performed by
investigators who are blind to the genotype or treatment
of the subject mice. Parameters routinely scored include
sniffing, following, physical contact, and allogrooming.58,62
Automated videotracking systems can accurately score
some of the simpler elements of social interac-
tions.34,35,44,63,64
Tendency to spend time with a novel mouse versus a
novel nonsocial object is evaluated in a social approach
apparatus (Figure 1). This 3-chambered assay, which was
developed by our team to provide a simple measure of
general sociability,30 is widely used as an initial, high-
throughput test for social deficits in mouse models of
autism.27,32,34,38,41,64-70
Second diagnostic category
Social communication in rodents is mostly through the
emission and detection of olfactory pheromones, and
perhaps to a lesser extent, the emission and detection of
ultrasonic vocalizations.40,44,55,57,59,60,71-74 Olfactory commu-
nication is assayed by time spent sniffing olfactory stim-
uli from novel mice, and identification of novel versus
familiar mice through olfactory cues.36,75,76
Vocal communication is assayed by recording ultra-
sonic vocalizations emitted during social interactions77
(Figure 2). Number of calls and their properties are
subsequently scored by investigators. Software is avail-
able for quantifying some of the simpler parameters.
Different patterns of ultrasonic vocalizations are emit-
ted by separated pups, adult males interacting with
estrus females or urine from estrus females, adult
females interacting with each other, and adult male res-
idents in response to an intruder.72,78
The anatomical and neurobiological substrates of olfac-
tory and ultrasonic communication in mice do not pre-
cisely map onto the biological substrates of language and
visual social communication in humans. In addition, con-
siderably more work is needed to fully understand the
communication value of ultrasonic vocalizations in mice.
Mouse models of autism - Crawley Dialogues in Clinical Neuroscience - Vol 14 . No. 3 . 2012
295
13_AG_1002_BA_INTERIEUR.qxd:DCNS#54  10/09/12  22:17  Page 295
At present, the existing tasks offer a reasonable start for
discovering mechanistic similarities between species.
Face validity of these mouse social interaction and com-
munication tasks to the tendencies of people with autism
to engage in less social approach and interaction, and to
respond appropriately to complex social cues, remains
inferential. We cannot know what a mouse is thinking,
feeling, or intending, but only the quantifiable external
expressions of those internal states.
Third diagnostic category
Mice with various genetic mutations exhibit spontaneous
motor stereotypies such as circling and vertical jumping,
and spontaneous repetitive behaviors such as long bouts
of self-grooming and excessive digging in the litter
(Figure 3). Assays generally focus on the number of bouts
of the behavior, or the cumulative time engaged in the
behavior, during a defined test session of 10 minutes or
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Figure 1. (a) Social approach apparatus for assaying sociability in mice.
The subject mouse begins in the empty center chamber of a
three-chambered Plexiglas apparatus. A novel object, an
inverted wire pencil cup, is placed in one side chamber. A novel
mouse, who has not been in visual, olfactory, or tactile contact
with the subject, is placed inside an identical wire control cup
in the opposite side chamber. Over a 10-minute test session,
the automated photocells and software score the amount of
time the subject mouse spends in each of the three chambers.
The number of entries into each compartment is simultaneously
recorded as an internal control for general exploratory activity.
Time spent engaged in bone fide social interactions with the
novel mouse, and directed exploration of the novel object, are
subsequently scored from digital videotapes of the session, by
investigators uninformed of the genotype or treatment con-
dition. Photograph by Dr Mu Yang, contributed by the author.
(b) Social approach chamber time scores in adult Engrailed2
(En2) knockout mice. Normal sociability is defined as more time
spent in the chamber with the novel mouse than in the cham-
ber with the novel object, and more time spent sniffing the
novel mouse than sniffing the novel object. Wild-type littermate
controls and heterozygotes displayed normal sociability on the
chamber time parameter, while En2 null mutants failed to dis-
play sociability on this parameter. 
Reproduced from reference 170: Brielmaier J, Matteson PG, Silverman
JL, et al. Autism-relevant social abnormalities and cognitive deficits in
engrailed-2 knockout mice. PLoS One. 2012;7:e40914.
(c) Social approach sniff time scores in adult En2 mice. Wild-
type littermate controls and heterozygotes displayed normal
sociability on the sniff time parameter, while En2 null mutants
failed to display sociability on this parameter. Time spent sniff-
ing the novel mouse is a more direct measure of social inter-
actions, and usually more sensitive to mutations. 
Reproduced from reference 170: Brielmaier J, Matteson PG, Silverman
JL, et al. Autism-relevant social abnormalities and cognitive deficits in
engrailed-2 knockout mice. PLoS One. 2012;7:e40914.
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longer.40,58,65,79-81 Restricted interests, insistence on same-
ness, and special interests are more challenging diagnos-
tic features of autism to model in mice. Perseveration of
spatial habits, such as difficulty in learning a new location
of a reinforcer in a T-maze or water maze after the initial
learning of a first location, has been employed with some
success in mouse models of autism.82,83
Associated symptoms
Established, standardized tests are available in the volu-
minous behavioral neuroscience literature for most of the
associated symptoms of autism.46,84-86 Neurodevelopmental
milestones are scored from postnatal day 2 to postnatal
day 18 on physical attributes such as body length and eye
opening, and behavioral attributes such as responses to
handling and the righting reflex. Spontaneous seizures are
scored with a rating scale or EEG electroencephalograhy.
Learning and memory tests for mice include Morris water
maze spatial navigation tasks, contextual and cued fear-
conditioned freezing after exposure to an aversive foot-
shock, and operant nose-poke and touch-screen rein-
forcement schedules. 
Anxiety-related tests for rodents are primarily
approach-avoidance conflicts. Mice are nocturnal. They
prefer to be in dimly lit, enclosed environments. The cur-
rent gold standard for anxiety-like tests for mice is the
elevated plus-maze, which consists of two open and two
enclosed arms, raised 1 meter from the floor, thus offer-
ing the choice between enclosed spaces and a high drop-
off ledge.85 The corroborating light↔dark test consists of
Mouse models of autism - Crawley Dialogues in Clinical Neuroscience - Vol 14 . No. 3 . 2012
297
Figure 2. (a) Ultrasonic vocalizations are recorded in adult mice engaged
in social interactions, using an ultrasonic microphone and spe-
cialized software. Photograph by Dr Jennifer Brielmaier, con-
tributed by the author. 
(b) Ultrasonic vocalization call categories in adult C57BL/6J mice,
an inbred strain with normal sociability. 
Reproduced from ref 153: Scattoni M, Ricceri L, Crawley J. Unusual repertoire
of vocalizations in adult BTBR T+tf/J mice during three types of social encoun-
ters. Genes Brain Behav. 2011;10:44-56. Copyright © Munskgaard 2011. 
(c) C57BL/6J adult male mice emit high numbers of ultrasonic
vocalizations, while BTBR adult male mice emit low numbers of
ultrasonic vocalizations, during a 5-minute session with an estrus
female mouse. BTBR T+tf/J (BTBR) is an inbred strain of mice that
displays robust, well-replicated social deficits on multiple
tasks,58,62,147 markedly fewer vocalizations during social interac-
tion sessions,59,153,154 and high levels of repetitive self-grooming
and marble burying,58,62,83 representing the three diagnostic cri-
teria for autism. 
Reproduced from ref 154: Wohr M, Roullet FI, Crawley JN. Reduced scent
marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of
autism. Genes Brain Behav. 2011;10:35-43. Copyright © Munksgaard 2011
N
u
m
b
er
 o
f 
u
lt
ra
so
n
ic
 v
o
ca
liz
at
io
n
s
Session time (sec)
Complex
Downward Chevron Short Composite Frequency
steps
Flat
Unstructured UpwardTwo-component
a b c
Ten categories of mouse adult calls
2a
2c
2b
0
10
20
30
40
C57BL/6J (n=15)
BTBR T+tf/J (n=15)
50
a
500 150100 200 250 300
13_AG_1002_BA_INTERIEUR.qxd:DCNS#54  10/09/12  22:17  Page 297
a two-compartment apparatus in which one chamber is
dark and enclosed while the other chamber is open and
brightly lit.87,88 Mice spend more time in the closed arms
of the elevated plus-maze and more time in the dark
compartment of the light↔dark apparatus. Excessive
anxiety-like traits are interpreted when the preference
is unusually high for the closed arms and for the dark
compartment. Anxiolytic-like treatment responses are
interpreted when mice venture out more frequently into
the open arms of the elevated plus-maze and the
brightly lit chamber of the light↔dark box.
Responses to sensory stimuli include acoustic startle,
olfactory habituation and dishabituation to a series of
non-social and social odors, and the hot plate and tail
flick thermal tests. Hyperactivity is scored from auto-
mated parameters of locomotion in a novel open field.
Unusual sleep patterns are scored by observations of the
home cage during the daylight sleeping hours and during
the nighttime active hours, and/or by EEG recordings.
Optimal animal models should incorporate: (i) face valid-
ity, ie, close analogies to the defining features of the
human syndrome; (ii) construct validity, ie, the biological
dysfunction that causes the human disease, such as a gene
mutation or anatomical abnormality; and (iii) predictive
validity, ie, responsiveness to treatments that prevent or
reverse symptoms in the human disease. The best animal
models of autism and related developmental disorders
will maximize face, construct, and predictive validities. At
present this combination represents a very small subset
of the model systems in use, particularly for neurodevel-
opmental disorders in which no effective therapeutics
exist to test predictive validity of the animal model. The
selected examples below are designed to illustrate the
progress and promise of the mouse modeling approach
in autism basic research and therapeutic development.
Our goal is to systematically analyze the wealth of
emerging animal models of neurodevelopmental disor-
ders, understand the strengths and weaknesses of each,
gain basic knowledge about phenotypic outcomes, and
employ the best model systems for treatment discovery.
How do we discover therapeutics using
mouse models?
The unmet medical need for effective treatments for
neurodevelopmental disorders is striking. The number
of reported cases of autism has risen rapidly over the
past decade.89,90 This rapid rise is largely a function of bet-
ter diagnostic instruments and public awareness,
although possible environmental causes and gene x envi-
ronment interactions are under investigation.91-93
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Figure 3. (a) Unusually high levels of spontaneous repetitive self groom-
ing, in which the normal pattern of grooming behaviors are
present but the bouts of grooming are strikingly prolonged, are
measured over a 10-minute session in which the subject mouse
is in an empty cage. Digital videos of the session are scored by
an investigator uninformed of the genotype or treatment con-
dition. Photograph by Dr Mu Yang, contributed by the author. 
(b) High levels of repetitive self-grooming are displayed by
adult BTBR mice as compared with C57BL/6J mice. In this
cross-fostering experiment, self-grooming scores in adults
were found to be independent of the strain of the dam that
raised the pup. Reproduced from ref 55: Panksepp JB, Jochman KA,
Kim JU, et al. Affiliative behavior, ultrasonic communication and social
reward are influenced by genetic variation in adolescent mice. PLoS
One. 2007;2:e351. Copyright Public Library of Science 2007
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Personal and financial costs are high, to the affected
individuals, their families, schools, and health care
providers. At present the only effective interventions are
intensive behavioral therapies.26,94 The only pharmaco-
logical treatments approved by the US Food and Drug
Administration are risperidone and aripiprazole:
Risperdol™ and Abilify.™ Their approved use is solely
for the associated “irritability,” which includes aggres-
sion, self-injury, and tantrums.95
A major revelation from the genetic association studies is
that the most frequent mutations in autism are in genes
that mediate the formation and maturation of synapses,
particularly the postsynaptic densities, dendritic spines, and
signaling mechanisms downstream from receptors medi-
ating excitatory neurotransmission.96-100 Pharmacological
agents that alter synaptic functions are already available
to some extent, and next-generation compounds are under
development.101-104 To evaluate the ability of novel drug
treatments to reverse and/or prevent the symptoms of dis-
eases, biomedical researchers often begin by testing
exploratory compounds in appropriate animal models.
Robust behavioral phenotypes with face validity to autism,
in mouse models with construct validity to autism spec-
trum disorders, hold great promise as preclinical tools for
discovering effective treatments for components of autism
spectrum disorders. 
Because rodents are similar to humans in many aspects
of biochemistry, physiology, anatomy, and genetics, mice
and rats are routinely employed in biomedical research
as translational systems. Compounds that reverse behav-
ioral and biological phenotypes in mouse models of
autism offer leads which may be worth pursuing in
human clinical trials. However, species differences exist
in drug metabolism, alternate biochemical pathways,
genetic variants, and toxicology. As in any field of bio-
medical research employing model systems, 100% pre-
dictive validity of efficacy and practicality in humans
cannot be expected.
Keeping these caveats in mind, we design rigorous meth-
ods to evaluate proposed therapeutic interventions for
autism spectrum disorders for their ability to reverse
and/or prevent the major phenotypes in mouse mod-
els.29,43 Behavioral pharmacologists test acute and chronic
drug treatments, across a dose range, at various time
points after administration, and assay for the most
robust autism-relevant behaviors, in the strongest mouse
models. Examples of some of the successes are described
in the next section.
Mouse models with high translational value
Cell surface adhesion glycoproteins 
Cell surface adhesion glycoproteins are a primary mech-
anism through which connections of presynaptic axons
and postsynaptic dendrites are elaborated in neuronal
synapses.97,105 Mutations in cell surface protein genes
have been reported with comparatively high frequency
in neurodevelopmental disorders. Individuals with
autism have been identified with mutations in
NEUREXIN1, NEUROLIGIN3, NEUROLIGIN4,
SHANK2, SHANK3, and CNTNAP2. For each of these
rare mutations, a small number of individuals with the
mutations who meet the diagnostic criteria for autism
spectrum disorder has been identified.106-109 Mice with
homologous mutations in these genes are available from
several excellent molecular genetics laboratories and
from The Jackson Laboratory repository. 
Shank3 knockout mice 
Shank3 knockout mice present a particularly fascinating
example of the importance of the location of the muta-
tion within the gene. The Shank3 gene includes an
ankyrin repeat domain, a PDZ domain, and a Homer
binding domain.110-112 Five distinct lines of Shank3 knock-
out mice with mutations at these various sites were gen-
erated and phenotyped in the past 2 years.71,81,113,114 Two
lines of Shank3 knockouts containing the mutation at
the ankyrin domain displayed impairments in excitatory
neurotransmission and long-term potentiation, but were
predominantly normal on standard measures of socia-
bility, with only small genotype differences detected in
ultrasonic vocalizations and repetitive behavior.71,81
Inserting the mutation at the Homer binding site
resulted in mice with more social interactions, primarily
in the form of aggression, along with mostly normal den-
dritic spines, reduced long-term potentiation, and
enhanced long-term depression.113 When the mutation
was in the PDZ domain, Shank3 knockouts displayed
much more severe phenotypes, including high sponta-
neous self-grooming resulting in skin lesions, impaired
sociability, reduced corticostriatal excitatory transmis-
sion, longer dendritic spines, and lower density of den-
dritic spines, as compared with wild-type controls.81
These divergent outcomes of mutations at differing sites
within the same gene provide a unique opportunity to
Mouse models of autism - Crawley Dialogues in Clinical Neuroscience - Vol 14 . No. 3 . 2012
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understand the binding partners and their downstream
signaling actions that determine the severity of symp-
toms in humans. For example, deficits in mGluR5 sig-
naling have been reported after Shank3 knockdown in
neuronal cultures.115 Augmentation of mGluR5 activity
could be beneficial in cases of autism with SHANK3
mutations, and in individuals with Phelan-McDermid
syndrome, an intellectual disability syndrome in which
the SHANK3 mutation is central to the 22q13 chromo-
somal deletion.108
Contactin associated protein 2 (Cntnap2)
Contactin associated protein 2 (Cntnap2), a member of
the neurexin superfamily, plays a role in neuron-glia
interactions and neuronal migration during early brain
maturation. Mutations in CNTNAP2 are associated with
autism in a small number of individuals, particularly with
language disabilities.107,116 Cntnap2 knockout mice were
generated to understand the actions of this protein on
brain development and autism-relevant behaviors.40
Seizures were detected in 9 out of 10 null mutants. Social
behaviors were impaired on the 3-chambered task, dur-
ing reciprocal interactions, and in home cage nesting.
Repetitive self-grooming was elevated. Resistance to
change was seen in the Morris water maze, in which the
initial learning was normal but the Cntnap2 knockouts
failed the reversal test when the escape platform location
was changed. Less spontaneous alternation in a T-maze
was seen in the null mutants, concomitant with moderate
hyperactivity. Reduced number of GABAergic interneu-
rons and impaired migration of cortical projection neu-
rons in this line of Cntnap2 mice underlie their seizures
and some of their behavioral abnormalities. The
Geschwind team proceeded to test risperidone, the
antipsychotic approved by the US Food and Drug
Administration for the treatment of irritability in autism.
At 0.2 mg/kg IP daily for 7 days, a dose and regimen
which did not affect locomotion in the wildtype controls,
risperidone reduced the hyperactivity and repetitive self-
grooming in Cntnap2 null mutant mice.40 Social behaviors
were unaffected by the treatment with risperidone, which
is an atypical antipsychotic.
Single gene mutations, chromosomal deletions, and
duplications cause a variety of neurodevelopmental dis-
orders, including Fragile X, Rett, Angelman, Prader-
Willi, Smith-Lemli-Opitz, Timothy, Williams, and Phelan-
McDermid syndromes, and tuberous sclerosis.97,108 A
surprisingly large number of these de novo mutations
code for signaling proteins that mediate the biochemical
events downstream to postsynaptic neurotransmitter
receptors. Interactome network analyses revealed con-
vergences in genes that mediate transcriptional and
splicing mechanisms that may be dysregulated in autism
spectrum disorders.117 Mutant mouse models of many of
these syndromes have been generated.43,44,114,118-122 While
clinically distinct disorders caused by known single gene
mutations suggest straightforward targets, as compared
with complex disorders such as cases of autism in which
the genetic substrates are unknown, increasing knowl-
edge about the actions of downstream signaling proteins
could identify pharmacological interventions which tar-
get key mechanistic sites in convergent biochemical cas-
cades. Mice with homologous mutations are being
employed as translational tools to evaluate convergent
downstream target mechanisms, and to screen com-
pounds that yield useful interventions at those sites. 
Tuberous sclerosis
Tuberous sclerosis, caused by a mutation in the Tsc1 or
Tsc2 gene, is characterized by benign tubers in the cere-
bral cortex, seizures, a high incidence of intellectual
impairment, and frequent comorbidity with autism.123,124
Tsc1 and Tsc2, which dimerize, are downstream targets
of the PI3K/Akt postsynaptic signaling pathway ele-
ments that bind to mTORC2, and regulate mTORC1 at
a further downstream site.125 mTOR, the mammalian
target of rapamycin, is a serine/threonine kinase which
regulates many facets of brain development and
cytoskeletal organization.126 Deletion of Tsc1 in knock-
out mice, hippocampal slices, or cortical cultures
resulted in enlarged brains, large dysmorphic astrocytes,
decreased myelination, reductions in γ-aminobutyric
acid (GABA)-ergic interneurons in the cerebral cortex,
and loss of mGluR-dependent long-term depres-
sion.126,127 Mice with mutations in Tsc2 display neuronal
hypertrophy, reduced long-term potentiation in hip-
pocampal slices, impaired hippocampally mediated fear
conditioning, and impaired water maze learning.128
Treatment with the mTOR inhibitor rapamycin for 5
days reversed the fear conditioning deficit and
improved water maze learning, along with reducing
brain weight and increasing survival.128
This early demonstration of a pharmacological rescue of
phenotypes in a mouse model of a neurodevelopmental
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disorder sparked optimism for treating disorders caused
by perturbations in signal transduction.129 In a separate
mutant line, 4 weeks of treatment with rapamycin
reduced the macroencephaly and increased the low
social interaction in mice with a mutation in Pten, an
upstream regulator of mTOR that is implicated in can-
cers, seizures, and autism.38 Rapalogs, analogs of mTOR,
are in clinical trials for cancers.130 Rapalogs and com-
pounds targeting PI3K and Akt131 present possibilities
for therapeutic interventions in neurodevelopmental dis-
orders with underlying mechanisms in the mTOR sig-
naling pathway.
Fragile X syndrome 
Fragile X syndrome is the most frequent genetic cause
of intellectual disabilities. Constriction at the end of the
X chromosome, termed a fragile site, is associated with
a dramatic expansion of CGG triplet repeats, which
transcriptionally silence the FMR1 gene.132,133 Fragile X
mental retardation protein (FMRP) is highly expressed
in the brain, where it negatively regulates the synthesis
of a large number of downstream proteins.134 Mice with
a mutation in Fmr1 display impairments in long-term
potentiation, unusual social behaviors, and some unusual
cognitive and anxiety-related behaviors.135-139
One functional consequence of the FMR1 mutation is
upregulation of mGluR5 receptors.140 Bear and col-
leagues discovered that crossing mGluR5 knockout mice
with Fmr1 knockout mice rescued the impaired long-
term depression, elevated the dendritic spine densities
in the hippocampus, and attenuated seizures.141 Negative
allosteric modulators of the mGluR5 receptor were
therefore postulated as potential treatments for Fragile
X Syndrome. Clinical trials are in progress to test this
hypothesis.142 Approximately 30% of individuals with
Fragile X syndrome meet the diagnostic criteria for
autism.143 Considering this high comorbidity, we rea-
soned that a treatment effective in Fragile X Syndrome
might act through a pathway convergent with other risk
genes for autism.144,145 We discovered that the prototypic
mGluR5 antagonist 6-methyl-2-(phenylethynyl) pyridine
(MPEP), and GRN-529. a more selective negative
allosteric modulators of the mGluR5 receptor, reduced
the high levels of repetitive self-grooming in BTBR
mice,79,146 an inbred strain that displays robust social
deficits, low vocalizations in social settings, and high
repetitive self-grooming and digging.42,58,60,65,78,79,147,148 In
addition, GRN-529 reduced the high levels of stereo-
typed jumping that characterize another inbred strain,
C58/J.80,146,149 Further, MPEP reduced marble burying in
Fmr1 knockout mice, reduced stereotypies in Swiss-
Webster mice, and reduced repetitive self-grooming and
marble burying in mice pretreated prenatally with val-
proic acid.14,150,151 These reports lend credence to the
notion that interventions acting through mGluR5 recep-
tors could confer specific benefits for treating repetitive
behaviors, a major component of the third diagnostic
symptom of autism.
Conclusions
Promising early findings of therapeutic rescues in mouse
models have energized the rational search for pharma-
cological treatments of autism spectrum disorder. While
the optimal developmental period for pharmacological
intervention remains to be determined, adults with
autism will likely be recruited for the first clinical trials,152
since the risks of adverse drug reactions are predicted to
be greater in children. Challenges will include discover-
ing the critical window during development and/or
adulthood at which interventions are useful, dosages, and
treatment regimens which minimize toxicity. We have
taken the first step in a long journey. ❏
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